147 related articles for article (PubMed ID: 11850275)
1. In vitro activities of the des-fluoro(6) Quinolone BMS-284756 against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections.
Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez H
Antimicrob Agents Chemother; 2002 Mar; 46(3):866-70. PubMed ID: 11850275
[TBL] [Abstract][Full Text] [Related]
2. Activity of gatifloxacin compared to those of five other quinolones versus aerobic and anaerobic isolates from skin and soft tissue samples of human and animal bite wound infections.
Goldstein EJ; Citron DM; Merriam CV; Tyrrell K; Warren Y
Antimicrob Agents Chemother; 1999 Jun; 43(6):1475-9. PubMed ID: 10348774
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro activities of ABT-773 against aerobic and anaerobic pathogens isolated from skin and soft-tissue animal and human bite wound infections.
Goldstein EJ; Citron DM; Merriam CV; Warren Y; Tyrrell K
Antimicrob Agents Chemother; 2000 Sep; 44(9):2525-9. PubMed ID: 10952607
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro activities of GAR-936 against aerobic and anaerobic animal and human bite wound pathogens.
Goldstein EJ; Citron DM; Merriam CV; Warren Y; Tyrrell K
Antimicrob Agents Chemother; 2000 Oct; 44(10):2747-51. PubMed ID: 10991855
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humans.
Goldstein EJ; Citron DM; Hudspeth M; Hunt Gerardo S; Merriam CV
Antimicrob Agents Chemother; 1997 Jul; 41(7):1552-7. PubMed ID: 9210683
[TBL] [Abstract][Full Text] [Related]
6. Linezolid activity compared to those of selected macrolides and other agents against aerobic and anaerobic pathogens isolated from soft tissue bite infections in humans.
Goldstein EJ; Citron DM; Merriam CV
Antimicrob Agents Chemother; 1999 Jun; 43(6):1469-74. PubMed ID: 10348773
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro activities of DU-6859a, levofloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against 387 aerobic and anaerobic bite wound isolates.
Goldstein EJ; Citron DM; Hunt Gerardo S; Hudspeth M; Merriam CV
Antimicrob Agents Chemother; 1997 May; 41(5):1193-5. PubMed ID: 9145900
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro activity of ertapenem and 11 other antimicrobial agents against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections.
Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell K; Fernandez H
J Antimicrob Chemother; 2001 Nov; 48(5):641-51. PubMed ID: 11679553
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 405 aerobic and anaerobic pathogens isolated from skin and soft tissue infections from animal and human bites.
Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
J Antimicrob Chemother; 2002 Sep; 50(3):411-20. PubMed ID: 12205068
[TBL] [Abstract][Full Text] [Related]
10. Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans.
Goldstein EJ; Citron DM; Hunt Gerardo S; Hudspeth M; Merriam CV
Antimicrob Agents Chemother; 1998 May; 42(5):1127-32. PubMed ID: 9593139
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro activities of azithromycin, Bay y 3118, levofloxacin, sparfloxacin, and 11 other oral antimicrobial agents against 194 aerobic and anaerobic bite wound isolates.
Goldstein EJ; Nesbit CA; Citron DM
Antimicrob Agents Chemother; 1995 May; 39(5):1097-100. PubMed ID: 7625795
[TBL] [Abstract][Full Text] [Related]
12.
Goldstein EJC; Citron DM; Tyrrell KL; Leoncio ES
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373186
[TBL] [Abstract][Full Text] [Related]
13. Comparative susceptibilities of 173 aerobic and anaerobic bite wound isolates to sparfloxacin, temafloxacin, clarithromycin, and older agents.
Goldstein EJ; Citron DM
Antimicrob Agents Chemother; 1993 May; 37(5):1150-3. PubMed ID: 8390810
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756.
Fung-Tomc JC; Minassian B; Kolek B; Huczko E; Aleksunes L; Stickle T; Washo T; Gradelski E; Valera L; Bonner DP
Antimicrob Agents Chemother; 2000 Dec; 44(12):3351-6. PubMed ID: 11083639
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of garenoxacin (BMS-284756) against 170 clinical isolates of nine Pasteurella species.
Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
Antimicrob Agents Chemother; 2002 Sep; 46(9):3068-70. PubMed ID: 12183274
[TBL] [Abstract][Full Text] [Related]
16. Comparative activities of cefuroxime, amoxicillin-clavulanic acid, ciprofloxacin, enoxacin, and ofloxacin against aerobic and anaerobic bacteria isolated from bite wounds.
Goldstein EJ; Citron DM
Antimicrob Agents Chemother; 1988 Aug; 32(8):1143-8. PubMed ID: 3190202
[TBL] [Abstract][Full Text] [Related]
17. Trovafloxacin compared with levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite-wound pathogens.
Goldstein EJ; Citron DM; Hudspeth M; Hunt Gerardo S; Merriam CV
J Antimicrob Chemother; 1998 Mar; 41(3):391-6. PubMed ID: 9578167
[TBL] [Abstract][Full Text] [Related]
18. In vitro activities of ABT-492, a new fluoroquinolone, against 155 aerobic and 171 anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis.
Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
Antimicrob Agents Chemother; 2003 Sep; 47(9):3008-11. PubMed ID: 12937015
[TBL] [Abstract][Full Text] [Related]
19. Role of anaerobic bacteria in bite-wound infections.
Goldstein EJ; Citron DM; Finegold SM
Rev Infect Dis; 1984; 6 Suppl 1():S177-83. PubMed ID: 6372026
[TBL] [Abstract][Full Text] [Related]
20. In vitro activities of a new des-fluoroquinolone, BMS 284756, and seven other antimicrobial agents against 151 isolates of Eikenella corrodens.
Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez H
Antimicrob Agents Chemother; 2002 Apr; 46(4):1141-3. PubMed ID: 11897609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
